Tran, L., Tran, Z. V., & Vu, F. (2024). Phase 3 Clinical Protocol: Placebo‐Controlled, Double‐Blind, Parallel‐Group to Study Safety and Efficacy of NA‐831 in Combination with Lecanemab in Subjects with Early Alzheimer’s Disease. Alzheimer's & dementia, 20(S8), -n/a. https://doi.org/10.1002/alz.095755
Citace podle Chicago (17th ed.)Tran, Lloyd, Zung Vu Tran, a Fern Vu. "Phase 3 Clinical Protocol: Placebo‐Controlled, Double‐Blind, Parallel‐Group to Study Safety and Efficacy of NA‐831 in Combination with Lecanemab in Subjects with Early Alzheimer’s Disease." Alzheimer's & Dementia 20, no. S8 (2024): -n/a. https://doi.org/10.1002/alz.095755.
Citace podle MLA (9th ed.)Tran, Lloyd, et al. "Phase 3 Clinical Protocol: Placebo‐Controlled, Double‐Blind, Parallel‐Group to Study Safety and Efficacy of NA‐831 in Combination with Lecanemab in Subjects with Early Alzheimer’s Disease." Alzheimer's & Dementia, vol. 20, no. S8, 2024, pp. -n/a, https://doi.org/10.1002/alz.095755.